Variable | Values | P Value | |
---|---|---|---|
HCM(32) | Normal(34) | ||
Clinical baseline parameters | |||
Age (years) | 47 ± 14 | 46 ± 12 | 0.779 |
Male | 19 (32) | 19 (34) | |
Heart Rate (bpm) | 70 ± 11 | 72 ± 12 | 0.391 |
NYHA Class | |||
I | (30)32 | ||
II | (2)32 | ||
III | (0)32 | ||
IV | (0)32 | ||
Medical treatment | |||
β-Blockers | (27)32 | ||
Calcium channel blockers | (5)32 | ||
Disopyramide | (0)32 | ||
Diuretics | (0)32 | ||
ICD | (0)32 | ||
2D echocardiographic characteristics | |||
LAd (mm) | 42.06 ± 4.91 | 35.09 ± 3.38 | < 0.001 |
IVDd (mm) | 19.41 ± 4.09 | 9.21 ± 1.04 | < 0.001 |
LVPWd (mm) | 10.19 ± 1.15 | 9.21 ± 1.04 | 0.001 |
LVEF(%) | 66.59 ± 6.39 | 65.20 ± 5.30 | 0.339 |
RVWd (mm) | 2.50 ± 0.51 | 2.47 ± 0.51 | 0.815 |
RVd middle (mm) | 29.28 ± 4.26 | 27.59 ± 3.02 | 0.066 |
RVd longitudinal (mm) | 52.31 ± 4.40 | 52.02 ± 5.16 | 0.812 |
RVd basal (mm) | 25.09 ± 3.44 | 24.62 ± 3.19 | 0.562 |
sPAP (mmHg) | 20.50 ± 4.69 | 18.56 ± 4.44 | 0.090 |
RAd middle (mm) | 37.09 ± 3.89 | 37.82 ± 3.83 | 0.445 |
RAd longitudinal (mm) | 48.93 ± 4.43 | 46.74 ± 3.42 | 0.027 |
TAPSE (mm) | 21.25 ± 2.06 | 21.94 ± 1.97 | 0.169 |
E | 0.48 ± 0.12 | 0.57 ± 0.09 | 0.001 |
A | 0.42 ± 0.09 | 0.40 ± 0.07 | 0.268 |
E/A | 1.19 ± 0.34 | 1.47 ± 0.28 | 0.001 |
S′(cm/s) | 10.41 ± 1.89 | 9.92 ± 1.42 | 0.234 |
E′ (cm/s) | −7.53 ± 2.04 | −8.74 ± 1.79 | 0.013 |
A′ (cm/s) | −11.13 ± 2.20 | −10.53 ± 2.37 | 0.289 |
E′/A′ | 0.71 ± 0.24 | 0.89 ± 0.34 | 0.016 |
TR grade | |||
Absence/Slight | (30)32 | (32)34 | |
Mild | (2)32 | (2)34 | |
Moderate | (0)32 | (0)34 | |
Severe | (0)32 | (0)34 |